Vergoeding 2016-2020 voor ATC-subgroep A02BA : H2-antagonisten
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| A02BA01 Cimetidine | 122.670 | 95.016 | 82.694 | 419.840 | 193.020 |
| A02BA02 Ranitidine (Zantac ®) | 1.986.800 | 2.182.400 | 2.217.300 | 1.826.000 | 1.037.600 |
| A02BA03 Famotidine (Famosin ®) | 182.580 | 173.270 | 256.730 | 505.910 | 1.766.000 |
| A02BA04 Nizatidine (Axid ®) | 40.199 | 34.555 | 33.653 | 37.380 | 4.847 |
| Totaal | 2.332.249 | 2.485.241 | 2.590.377 | 2.789.130 | 3.001.467 |